Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

BRAFV600E and KIT immunoexpression in early-stage melanoma.

Germano A, Cardili L, Carapeto FCL, Landman G.

An Bras Dermatol. 2019 Oct 17;94(4):458-460. doi: 10.1590/abd1806-4841.20198349. eCollection 2019.

2.

Intratumor Heterogeneity of KIT Gene Mutations in Acral Lentiginous Melanoma.

Comodo-Navarro AN, Fernandes M, Barcelos D, Carapeto FCL, GuimarĂ£es DP, de Sousa Moraes L, Cerutti J, Iwamura ESM, Landman G.

Am J Dermatopathol. 2019 Jul 29. doi: 10.1097/DAD.0000000000001475. [Epub ahead of print]

PMID:
31393283
3.

Long term safety of targeted internalization of cell penetrating peptide crotamine into renal proximal tubular epithelial cells in vivo.

Campeiro JD, Dam W, Monte GG, Porta LC, Oliveira LCG, Nering MB, Viana GM, Carapeto FC, Oliveira EB, van den Born J, Hayashi MAF.

Sci Rep. 2019 Mar 1;9(1):3312. doi: 10.1038/s41598-019-39842-7.

4.

Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma.

McKean M, Oba J, Ma J, Roth KG, Wang WL, Macedo MP, Carapeto FCL, Haydu LE, Siroy AE, Vo P, Hong DS, Eterovic AK, Patel KP, Bassett RL Jr, Grimm EA, Lazar AJ, Woodman SE.

J Invest Dermatol. 2019 Mar;139(3):728-731. doi: 10.1016/j.jid.2018.10.009. Epub 2018 Oct 25. No abstract available.

PMID:
30798855
5.

Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.

Fischer GM, Jalali A, Kircher DA, Lee WC, McQuade JL, Haydu LE, Joon AY, Reuben A, de Macedo MP, Carapeto FCL, Yang C, Srivastava A, Ambati CR, Sreekumar A, Hudgens CW, Knighton B, Deng W, Ferguson SD, Tawbi HA, Glitza IC, Gershenwald JE, Vashisht Gopal YN, Hwu P, Huse JT, Wargo JA, Futreal PA, Putluri N, Lazar AJ, DeBerardinis RJ, Marszalek JR, Zhang J, Holmen SL, Tetzlaff MT, Davies MA.

Cancer Discov. 2019 May;9(5):628-645. doi: 10.1158/2159-8290.CD-18-1489. Epub 2019 Feb 20.

6.

A Preexisting Rare PIK3CAE545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 Signaling.

Romano G, Chen PL, Song P, McQuade JL, Liang RJ, Liu M, Roh W, Duose DY, Carapeto FCL, Li J, Teh JLF, Aplin AE, Chen M, Zhang J, Lazar AJ, Davies MA, Futreal PA, Amaria RN, Zhang DY, Wargo JA, Kwong LN.

Cancer Discov. 2018 May;8(5):556-567. doi: 10.1158/2159-8290.CD-17-0745. Epub 2018 Mar 1.

7.

Oral treatment with a rattlesnake native polypeptide crotamine efficiently inhibits the tumor growth with no potential toxicity for the host animal and with suggestive positive effects on animal metabolic profile.

Campeiro JD, Marinovic MP, Carapeto FC, Dal Mas C, Monte GG, Carvalho Porta L, Nering MB, Oliveira EB, Hayashi MAF.

Amino Acids. 2018 Feb;50(2):267-278. doi: 10.1007/s00726-017-2513-3. Epub 2017 Dec 12.

PMID:
29235017

Supplemental Content

Loading ...
Support Center